FDA “People Power” Could Take Sequestration Hit – Hamburg
This article was originally published in The Tan Sheet
Executive Summary
The FDA commissioner says a budget sequester would slow implementation of FDA Safety and Innovation Act provisions and reduce some overseas inspections. More emphasis could be placed on using systems that target the riskiest facilities to reduce the number of onsite inspections, Hamburg says.
You may also be interested in...
FDA Widens Search For Medical Products, Tobacco Deputy Commissioner
The winning candidate would be the third to hold the position in two years. FDA published two notices because the position “requires senior scientific experience in addition to senior executive leadership” and to reach a large applicant pool.
FDA Widens Search For Medical Products, Tobacco Deputy Commissioner
The winning candidate would be the third to hold the position in two years. FDA published two notices because the position “requires senior scientific experience in addition to senior executive leadership” and to reach a large applicant pool.
Congress Targets Sequester-Proof User Fees For FDA
Rep. Sam Farr says Congressional Budget Office scoring problems prevent releasing FDA’s fiscal 2013 user fees from being held in the budget sequester, but an amendment will be proposed to ensure the agency’s fiscal 2014 fees are included in its appropriations.